Literature DB >> 316362

Tumor promoters and epidermal growth factor stimulate anchorage-independent growth of adenovirus-tranformed rat embryo cells.

P B Fisher, J H Bozzone, I B Weinstein.   

Abstract

Previous studies indicated that the potent tumor promoter 12--0--tetradecanoyl-phorbol-13-acetate (TPA) enhances transformation of rat embryo cells (2 degrees RE) by a mutant of human Ad5 (H5ts125). This study examines the effect of TPA, its structural analogs and epidermal growth factor (EGF) on anchorage-independent growth of a cloned population of H5ts125-transformed 2 degrees RE cells (clone E11). Both TPA and EGF (approximately 10(-8) M) induced a 3--5 fold increase in agar cloning efficiency of E11 cells. In addition, macroscopic colonies appeared earlier and were larger and more diffuse. The TPA analogs phorbol--12,13--didecanoate (PDD) and ingenol--3,20--dibenzoate also enhanced growth in agar of E11 cells, whereas phorbol, 4 alpha PDD and 4--0--meTPA, which are inactive as tumor promoters, failed to enhance agar growth. In contrast to the results obtained with E11 cells, TPA, PDD or ingenol--3,20--bidenzoate failed to induce growth in agar of normal 2 degrees RE cells. Dexamethasone (10(-5)--10(-6) M), trans retinoic acid (10(-5)--10(-6) M) and the protease inhibitors leupeptin, antipain and elastatinol did not inhibit the ability of TPA to enhance the growth of E11 cells in agar. The TPA-enhanced anchorage independence was a stable property, since subclones of E11 cells isolated from TPA-agar plates had a higher agar cloning efficiency than the parental E11 cells when retested in the absence of TPA. This effect of TPA does not appear to reflect simple selection of a subpopulation of cells. When the parental E11 cells were first cloned in monolayer culture in the absence of TPA, all ten randomly picked clones showed enhanced growth in agar in the presence of TPA. In addition, prior growth of E11 cells in monolayer culture in the presence of TPA did not enhance their subsequent growth in agar. This system therefore provides an example in which TPA appears to enhance the acquisition of a stable cell property, and thus may be a useful model for studying mechanisms of tumor promotion and progression.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 316362     DOI: 10.1016/0092-8674(79)90124-7

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  11 in total

1.  Antisense inhibition of the PTI-1 oncogene reverses cancer phenotypes.

Authors:  Z Su; N I Goldstein; P B Fisher
Journal:  Proc Natl Acad Sci U S A       Date:  1998-02-17       Impact factor: 11.205

2.  PEG-3, a nontransforming cancer progression gene, is a positive regulator of cancer aggressiveness and angiogenesis.

Authors:  Z Z Su; N I Goldstein; H Jiang; M N Wang; G J Duigou; C S Young; P B Fisher
Journal:  Proc Natl Acad Sci U S A       Date:  1999-12-21       Impact factor: 11.205

3.  Biotinylated epidermal growth factor: a useful tool for the histochemical analysis of specific binding sites.

Authors:  K Kayser; G Weisse; H J Gabius; T Hintze
Journal:  Histochem J       Date:  1990-08

4.  Altered growth properties of normal human cells induced by phorbol 12,13-didecanoate.

Authors:  R W Trewyn; H B Gatz
Journal:  In Vitro       Date:  1984-05

5.  PEA3 sites within the progression elevated gene-3 (PEG-3) promoter and mitogen-activated protein kinase contribute to differential PEG-3 expression in Ha-ras and v-raf oncogene transformed rat embryo cells.

Authors:  Z Su; Y Shi; R Friedman; L Qiao; R McKinstry; D Hinman; P Dent; P B Fisher
Journal:  Nucleic Acids Res       Date:  2001-04-15       Impact factor: 16.971

6.  Suppression of the progression phenotype in somatic cell hybrids occurs in the absence of altered adenovirus type 5 gene expression.

Authors:  G J Duigou; L E Babiss; D S Iman; J W Shay; P B Fisher
Journal:  Mol Cell Biol       Date:  1990-05       Impact factor: 4.272

7.  Modulation of adenovirus transformation by thyroid hormone.

Authors:  P B Fisher; D L Guernsey; I B Weinstein; I S Edelman
Journal:  Proc Natl Acad Sci U S A       Date:  1983-01       Impact factor: 11.205

8.  Tumor promoters alter the temporal program of adenovirus replication in human cells.

Authors:  P B Fisher; C S Young; I B Weinstein; T H Carter
Journal:  Mol Cell Biol       Date:  1981-04       Impact factor: 4.272

Review 9.  Selected approaches for rational drug design and high throughput screening to identify anti-cancer molecules.

Authors:  Michael Hedvat; Luni Emdad; Swadesh K Das; Keetae Kim; Santanu Dasgupta; Shibu Thomas; Bin Hu; Shan Zhu; Rupesh Dash; Bridget A Quinn; Regina A Oyesanya; Timothy P Kegelman; Upneet K Sokhi; Siddik Sarkar; Eda Erdogan; Mitchell E Menezes; Praveen Bhoopathi; Xiang-Yang Wang; Martin G Pomper; Jun Wei; Bainan Wu; John L Stebbins; Paul W Diaz; John C Reed; Maurizio Pellecchia; Devanand Sarkar; Paul B Fisher
Journal:  Anticancer Agents Med Chem       Date:  2012-11       Impact factor: 2.505

Review 10.  Chapter One---Cancer terminator viruses and approaches for enhancing therapeutic outcomes.

Authors:  Swadesh K Das; Siddik Sarkar; Rupesh Dash; Paul Dent; Xiang-Yang Wang; Devanand Sarkar; Paul B Fisher
Journal:  Adv Cancer Res       Date:  2012       Impact factor: 6.242

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.